Clinical Trials Logo
  1. Home
  2. Nicotine Dependence, Cigarettes
  3. NCT04805515

Impact of Nicotine Messaging on Nicotine Beliefs and Tobacco Use Behavior

Nicotine Dependence, Cigarettes Clinical Trial

Official title:
Impact of Nicotine Messaging on Nicotine Beliefs and Tobacco Use Behavior

Clinical Trial Summary

This is a 2-arm, randomized controlled, population based trial to test the impact of multiple exposures to brief nicotine corrective messages among adult tobacco cigarette smokers and non-smokers followed in waves over 12 weeks. The primary outcome, assessed at wave 1 (baseline), wave 2 (weeks 5-6), and wave 4 (weeks 11-13) is nicotine beliefs. Secondary outcomes assessed at the same time points include intention to use nicotine/tobacco products and nicotine/tobacco use.

Clinical Trial Description

This is a 2-arm, randomized controlled, population based trial to test the impact of multiple exposures to brief nicotine corrective messages among adult tobacco cigarette smokers and non-smokers followed for 12 weeks. The primary outcome, assessed at wave 1 (baseline), wave 2 (weeks 5-6), and wave 4 (weeks 11-13) is nicotine beliefs. Secondary outcomes assessed at the same time points include intention to use nicotine/tobacco products and nicotine/tobacco use. All participants will be recruited from a US national consumer research panel. Eligible participants will be U.S. adults ages 18+ who are enrolled members of the partnering consumer research panel. The sample will include non-smokers and smokers, oversampling current smokers (defined as smoking 100+ lifetime cigarettes and now smoking all or some days) to ensure the proportion of smokers in the sample reflects the ~15 % population smoking prevalence among adults. Panel members will be contacted by email with a brief study description and link to an eligibility screener and online informed consent form. Eligible and interested participants will complete the baseline (Wave 1) survey measures of nicotine beliefs and intentions/use of nicotine and tobacco products, after which they will be randomly assigned in equal numbers to the nicotine corrective message (NCM) intervention condition or the delayed message control condition. After completing the baseline survey, participants in the NCM condition will receive their first exposure to the corrective messages. In the Wave 2 survey, all participants will complete measures of nicotine beliefs and intentions/use of nicotine and tobacco products. Participants in the NCM condition will then receive their second exposure to study messages. Only participants in the NCM condition will receive the Wave 3 survey, which involves the third exposure to study messages. The Wave 4 survey will include the fourth exposure to study messages for those in the NCM condition and the final assessment of nicotine beliefs and intentions/use of nicotine and tobacco products for all participants. Upon completion of the final assessment, participants in the control condition will be exposed to the nicotine corrective messages and all participants will be directed to resources on quitting smoking. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04805515
Study type Interventional
Source University of Vermont
Contact
Status Completed
Phase N/A
Start date February 12, 2021
Completion date May 31, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT05477342 - Reducing Nicotine Addiction in Adolescent Smokers N/A
Completed NCT03011710 - Epidemiology and Acute Oral Effects Electronic Cigarette N/A
Recruiting NCT03191825 - Online Lapse Management Intervention N/A
Recruiting NCT03194919 - Negotiating a Quit Date or Not in Online Interventions N/A
Completed NCT03719391 - United States Pre-Market Tobacco Application Pharmacokinetics N/A
Completed NCT05538702 - Acute Oral Effects of Heated Tobacco Products N/A
Completed NCT02723162 - Translational Neuropsychopharmacology Research of Nicotine Addiction Phase 2
Completed NCT03194958 - Helping Poor Smokers Quit N/A
Completed NCT03593239 - Comparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy Smokers N/A
Completed NCT04830384 - Evaluation of LLLT/Music for Smoking Cessation N/A
Completed NCT02367391 - Penn State TXT2Quit Study N/A
Recruiting NCT05665465 - Neurobehavioral Mechanisms Linking Childhood Adversity to Increased Risk for Smoking Early Phase 1
Completed NCT03700112 - Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods. N/A
Terminated NCT02986711 - Penn State TXT2STAYQUIT Study- a Texting Study to Help Hospitalized Smokers Stay Quit N/A
Recruiting NCT05224154 - Re-Connect Application for Smoking Cessation N/A
Completed NCT03492463 - The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products Phase 2
Withdrawn NCT03473483 - Cigarette Harm Reduction With Electronic Cigarette Use N/A
Completed NCT04379388 - Improving Smoking Cessation in Socioeconomically-Disadvantaged Young Adults N/A
Active, not recruiting NCT04163081 - The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments N/A